Welcome to the Lilly Scientific Information Page for SABCS 2025
San Antonio Breast Cancer Symposium
San Antonio, TX
Quicklinks
See how Lilly supports external requests for provision of study drug and/or financial support.
To receive the latest science and disease state education from Lilly Oncology, be sure to follow us via @LillyOncMed
To receive the latest science and innovation, please be sure to follow us on LinkedIn.
Disclosures
WEDNESDAY
WEDNESDAY
WEDNESDAY
WEDNESDAY
THURSDAY
FRIDAY
- Disease State: Metastatic Breast Cancer
- Presented by: Komal Jhaveri
- Molecule(s): Imlunestrant
Imlunestrant With or Without Abemaciclib in Advanced Breast Cancer: Updated Efficacy Results From the Phase 3 EMBER-3 Trial
Trial(s) Overview:
FRIDAY
FRIDAY
FRIDAY
- Disease State: Breast Cancer
- Presented by: Komal Jhaveri
- Molecule(s): GRPR
A Phase 1 Study of LY4257496, a Novel GRPR-Targeted Radioligand Therapy, in Patients with GRPR-Positive Metastatic ER+ Breast Cancer and Other Advanced Solid Tumors - OMNIRAY (Trial in Progress)
Trial(s) Overview:
To receive the latest science and innovation from LillyMedical, be sure to follow us via our Twitter handle @LillyOncMed. See our community guidelines.
Contact Us
Call us
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)